Las Vegas Sands (LVS) Stock Spikes Mid-Day; Now Up 16%
Get Alerts LVS Hot Sheet
Price: $38.99 +0.88%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 7.7%
Revenue Growth %: +2.4%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 7.7%
Revenue Growth %: +2.4%
Join SI Premium – FREE
Shares of Las Vegas Sands (NYSE: LVS) have just spiked in mid-day trading. We are not hearing any news that could explain the drastic surge in price and volume.
After trading higher at the open, shares sunk into negative territory, bouncing between black and red, until just after 11am ET, when shares began spiking. In the last 10 minutes of trading, shares have skyrocketed from about $11.40 to over $12.70. The stock is now up more than 16% from yesterday's close.
Other big name gaming stocks are not responding similarly: shares of Wynn Resorts (Nasdaq: WYNN) are down 1%, while shares of MGM MIRAGE (NYSE: MGM) are down 5.6%.
Las Vegas Sands stock has been absolutely slaughtered over the last year. In October of 2007, shares of Las Vegas Sands were trading over $130, marking a more than 90% slide in about 12 months.
Las Vegas Sands Corp. and its subsidiaries develop multi use integrated resorts worldwide.
After trading higher at the open, shares sunk into negative territory, bouncing between black and red, until just after 11am ET, when shares began spiking. In the last 10 minutes of trading, shares have skyrocketed from about $11.40 to over $12.70. The stock is now up more than 16% from yesterday's close.
Other big name gaming stocks are not responding similarly: shares of Wynn Resorts (Nasdaq: WYNN) are down 1%, while shares of MGM MIRAGE (NYSE: MGM) are down 5.6%.
Las Vegas Sands stock has been absolutely slaughtered over the last year. In October of 2007, shares of Las Vegas Sands were trading over $130, marking a more than 90% slide in about 12 months.
Las Vegas Sands Corp. and its subsidiaries develop multi use integrated resorts worldwide.
You May Also Be Interested In
- Heidi L. O'Neill resigns from Lithia Motors board
- Future Money Acquisition gets Nasdaq notice over late 10-Q filing
- Tempest Therapeutics (TPST) files for 9.53M share offering by selling stockholders
Create E-mail Alert Related Categories
Corporate News, Insiders' BlogRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share